BUZZ-Aurinia Pharmaceuticals Inc: Hits 5-year high on positive data

Thu Oct 6, 2016 11:57am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drug developer's U.S.-listed shares up as much as 40.5 pct at $5.69; highest in more than 5 years

** Reports positive data from open-label study for its drug to treat a type of lupus

** Lupus is a condition where the body's immune system targets its own tissues

** The drug, voclosporin, is being developed to treat lupus nephritis, in which lupus targets the kidney, causing inflammation

** 7 out of 10 patients showed complete reduction in disease symptoms at week 24 of study when treated with the drug in combination with other treatments

** More than 22.5 mln shares traded, 9.4x 30-day moving avg

** Up to Wednesday's close, stock gained more than 60 pct YTD